Strategies at points of entry to reduce importation risk of COVID-19 cases and reopen travel

被引:57
作者
Dickens, Borame L. [1 ,2 ]
Koo, Joel R. [1 ,2 ]
Lim, Jue Tao [1 ,2 ]
Sun, Haoyang [1 ,2 ]
Clapham, Hannah E. [1 ,2 ]
Wilder-Smith, Annelies [3 ,4 ]
Cook, Alex R. [1 ,2 ]
机构
[1] Natl Univ Singapore, SawSwee Hock Sch Publ Hlth, 1E Kent Ridge Rd, Singapore 117549, Singapore
[2] Natl Univ Hlth Syst, 1E Kent Ridge Rd, Singapore 117549, Singapore
[3] London Sch Hyg & Trop Med, Dept Dis Control, Keppel St, London WC1E 7HT, England
[4] Heidelberg Univ, Heidelberg Inst Global Hlth, Neuenheimer Feld 365,R 004, D-69120 Heidelberg, Germany
基金
英国医学研究理事会;
关键词
Lockdown; travel restrictions; border measures; SARS-CoV-2; quarantine; isolation; air passengers;
D O I
10.1093/jtm/taaa141
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: With more countries exiting lockdown, public health safety requires screening measures at international travel entry points that can prevent the reintroduction or importation of the severe acute respiratory syndrome-related coronavirus-2. Here, we estimate the number of cases captured, quarantining days averted and secondary cases expected to occur with screening interventions. Methods: To estimate active case exportation risk from 153 countries with recorded coronavirus disease-2019 cases and deaths, we created a simple data-driven framework to calculate the number of infectious and upcoming infectious individuals out of 100 000 000 potential travellers from each country, and assessed six importation risk reduction strategies; Strategy 1 (S1) has no screening on entry, S2 tests all travellers and isolates test-positives where those who test negative at 7 days are permitted entry, S3 the equivalent but for a 14 day period, S4 quarantines all travellers for 7 days where all are subsequently permitted entry, S5 the equivalent for 14 days and S6 the testing of all travellers and prevention of entry for those who test positive. Results: The average reduction in case importation across countries relative to S1 is 90.2% for S2, 91.7% for S3, 55.4% for S4, 91.2% for S5 and 77.2% for S6. An average of 79.6% of infected travellers are infectious upon arrival. For the top 100 exporting countries, an 88.2% average reduction in secondary cases is expected through S2 with the 7-day isolation of test-positives, increasing to 92.1% for S3 for 14-day isolation. A substantially smaller reduction of 30.0% is expected for 7-day all traveller quarantining, increasing to 84.3% for 14-day all traveller quarantining. Conclusions: The testing and isolation of test-positives should be implemented provided good testing practices are in place. If testing is not feasible, quarantining for a minimum of 14 days is recommended with strict adherence measures in place.
引用
收藏
页数:8
相关论文
共 39 条
  • [1] The rise in travel-associated measles infections-GeoSentinel, 2015-2019
    Angelo, Kristina M.
    Libman, Michael
    Gautret, Philippe
    Barnett, Elizabeth
    Grobusch, Martin P.
    Hagmann, Stefan H. F.
    Gobbi, Federico
    Schwartz, Eli
    van Genderen, Perry J. J.
    Asgeirsson, Hilmer
    Hamer, Davidson H.
    [J]. JOURNAL OF TRAVEL MEDICINE, 2019, 26 (06)
  • [2] Potential for global spread of a novel coronavirus from China
    Bogoch, Isaac I.
    Watts, Alexander
    Thomas-Bachli, Andrea
    Huber, Carmen
    Kraemer, Moritz U. G.
    Khan, Kamran
    [J]. JOURNAL OF TRAVEL MEDICINE, 2020, 27 (02)
  • [3] COVID-19 Immunity Passport to Ease Travel Restrictions?
    Chen, Lin H.
    Freedman, David O.
    Visser, Leo G.
    [J]. JOURNAL OF TRAVEL MEDICINE, 2020, 27 (05)
  • [4] Chinazzi M, 2020, SCIENCE, V368, P395, DOI [10.1126/science.aba9757, 10.1101/2020.02.09.20021261]
  • [5] The effectiveness of full and partial travel bans against COVID-19 spread in Australia for travellers from China during and after the epidemic peak in China
    Costantino, Valentina
    Heslop, David J.
    MacIntyre, C. Raina
    [J]. JOURNAL OF TRAVEL MEDICINE, 2020, 27 (05)
  • [6] Institutional, not home-based, isolation could contain the COVID-19 outbreak
    Dickens, Borame L.
    Koo, Joel R.
    Wilder-Smith, Annelies
    Cook, Alex R.
    [J]. LANCET, 2020, 395 (10236) : 1541 - 1542
  • [7] An interactive web-based dashboard to track COVID-19 in real time
    Dong, Ensheng
    Du, Hongru
    Gardner, Lauren
    [J]. LANCET INFECTIOUS DISEASES, 2020, 20 (05) : 533 - 534
  • [8] Risk perceptions of COVID-19 around the world
    Dryhurst, Sarah
    Schneider, Claudia R.
    Kerr, John
    Freeman, Alexandra L. J.
    Recchia, Gabriel
    van der Bles, Anne Marthe
    Spiegelhalter, David
    van der Linden, Sander
    [J]. JOURNAL OF RISK RESEARCH, 2020, 23 (7-8) : 994 - 1006
  • [9] Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe
    Flaxman, Seth
    Mishra, Swapnil
    Gandy, Axel
    Unwin, H. Juliette T.
    Mellan, Thomas A.
    Coupland, Helen
    Whittaker, Charles
    Zhu, Harrison
    Berah, Tresnia
    Eaton, Jeffrey W.
    Monod, Melodie
    Ghani, Azra C.
    Donnelly, Christl A.
    Riley, Steven
    Vollmer, Michaela A. C.
    Ferguson, Neil M.
    Okell, Lucy C.
    Bhatt, Samir
    [J]. NATURE, 2020, 584 (7820) : 257 - +
  • [10] Preparedness and vulnerability of African countries against importations of COVID-19: a modelling study
    Gilbert, Marius
    Pullano, Giulia
    Pinotti, Francesco
    Valdano, Eugenio
    Poletto, Chiara
    Boelle, Pierre-Yves
    D'Ortenzio, Eric
    Yazdanpanah, Yazdan
    Eholie, Serge Paul
    Altmann, Mathias
    Gutierrez, Bernardo
    Kraemer, Moritz U. G.
    Colizza, Vittoria
    [J]. LANCET, 2020, 395 (10227) : 871 - 877